| Antigen detectable with this ELISA kit: |
Noggin (NOG) |
| Species reactivity: |
Homo sapiens (Human) |
| Range of detection: |
0, 0, 0, 1, 2, 5ng/mL, 156-10ng/mL The standard curve concentrations used for the ELISA&rsquo, 156ng/mL, 25ng/mL, 313ng/mL, 5ng/mL, 625ng/mL, s were 10ng/mL |
| Sensitivity: |
063ng/mL, The minimum detectable dose of this kit is typically less than 0 |
| Application: |
ELISA |
| Sample types tested for this ELISA kit: |
plasma, tissue homogenates and other biological fluids, Serum |
| Time for performing t hourse test: |
4, 5 hoursours |
| Test principle: |
10nm, After TMB substrate solution is added, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated, Next, Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated antibody specific to Noggin (NOG), The concentration of Noggin (NOG) in the samples is then determined by comparing the O, The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm &, The microtiter plate provided in this kit has been pre-coated with an antibody specific to Noggin (NOG), biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color, of the samples to the standard curve, only those wells that contain Noggin (NOG), D, The test principle applied in this kit is Sandwich enzyme immunoassay, plusmn |
| Storage and handling: |
Do not freeze any of the components of the ELISA kit, store all of the kit's components regrigerated at tempretaures between 2 and 6 degrees Celcius, Upon receipt |
| Advisory: |
Prior to use, briefly centrifuge these liquid components to collect all of the amount on the bottom of the vial, Due to transportation and handling issues small amounts of the liquid components of the ELISA kit may get trapped onto the seal or walls of the tubes |
| Properties: |
E05 478 566 350 170 or Enzyme-Linked Immunosorbent Assays, E05 478 566 350 170 or Enzyme-Linked Immunosorbent Assays |
| Test: |
ELISA Enzyme-linked immunosorbent assays Code 90320007 SNOMED |
| Gene target: |
Noggin (NOG) |
| Short name: |
Noggin (NOG) ELISA kit |
| Technique: |
&hellip, A sign detected by the Colorimetric detection OD optical density absorbance at 450 nm between 0 and 4 with an ELISA reader for 450 nm absortion, Also Enzyme-linked immunoassay, ELISA test kits can be sandwich ELISA, ELISA tests are enzyme linked immunoassays to detect human, ELISAs Enzyme-linked immunosorbent assay 90320007 SNOMED code are used by the medical researcher for detection of human, Genprice Inc, In sandwich ELISAS Enzyme-linked immunosorbent assay 9we use captor and detector antibodies, In single antibody ELISAs the antigen is coated and only a detector antibody is used, In this case the ratio on your graph will be inverse proportional with the antigen present in your sample, MeSH code E05 478 566 350 170 Enzyme-Linked Immunosorbent Assay, MeSH code E05 478 566 350 170 for Enzyme-Linked Immunosorbent Assay or ELISA kits, PROMT code 3841327 Immunoabsorbent assay tests, This is the desigation of other diagnostic analyzers and tests, Traditional competition antigen ELISAs are coated with a captor antibody and a competitive antigen is labelled with the chromogen, competitive have the SNOMED name 61461007 and the PROMT code for ELISA readers is 3841330, mouse, mouse or other proteins in serum, plasma, proteins are supplied in coated 96 well plates to be stored at +4°, the recognized authority tax ID 45-4304622 D-U-N-S number - 078440800, urine or biological fluids, C, ELISA kit |
| Host: |
antigen assay ELISA kit 1 Kit (96 Wells) |
| Alternative name: |
Noggin (noggin) Enzyme-linked immunosorbent assay reagent |
| Alternative technique: |
elisas |
| Alternative to gene target: |
Extracellular, NOG and IDBG-60160 and ENSG00000183691 and 9241, NOG and IDBG-647068 and ENSBTAG00000040282 and 538769, Nog and IDBG-208239 and ENSMUSG00000048616 and 18121, SYM1 and SYNS1, protein homodimerization activity, this GO :0000122 and negative regulation of transcription from RNA polymerase II promoter and biological process this GO :0001501 and skeletal system development and biological process this GO :0001649 and osteoblast differentiation and biological process this GO :0001655 and urogenital system development and biological process this GO :0001657 and ureteric bud development and biological process this GO :0001701 and in utero embryonic development and biological process this GO :0001706 and endoderm formation and biological process this GO :0001707 and mesoderm formation and biological process this GO :0001837 and epithelial to mesenchymal transition and biological process this GO :0001839 and neural plate morphogenesis and biological process this GO :0001843 and neural tube closure and biological process this GO :0005515 and protein binding and molecular function this GO :0005576 and extracellular region and cellular component this GO :0005615 and extracellular space and cellular component this GO :0007389 and pattern specification process and biological process this GO :0007399 and nervous system development and biological process this GO :0007411 and axon guidance and biological process this GO :0007417 and central nervous system development and biological process this GO :0007420 and brain development and biological process this GO :0008045 and motor neuron axon guidance and biological process this GO :0009953 and dorsal/ventral pattern formation and biological process this GO :0010629 and negative regulation of gene expression and biological process this GO :0019955 and cytokine binding and molecular function this GO :0021510 and spinal cord development and biological process this GO :0021533 and cell differentiation in hindbrain and biological process this GO :0021915 and neural tube development and biological process this GO :0021983 and pituitary gland development and biological process this GO :0030336 and negative regulation of cell migration and biological process this GO :0030509 and BMP signaling pathway and biological process this GO :0030510 and regulation of BMP signaling pathway and biological process this GO :0030514 and negative regulation of BMP signaling pathway and biological process this GO :0035019 and somatic stem cell maintenance and biological process this GO :0042060 and wound healing and biological process this GO :0042474 and middle ear morphogenesis and biological process this GO :0042733 and embryonic digit morphogenesis and biological process this GO :0042803 and protein homodimerization activity and molecular function this GO :0045596 and negative regulation of cell differentiation and biological process this GO :0045668 and negative regulation of osteoblast differentiation and biological process this GO :0045944 and positive regulation of transcription from RNA polymerase II promoter and biological process this GO :0048318 and axial mesoderm development and biological process this GO :0048570 and notochord morphogenesis and biological process this GO :0048646 and anatomical structure formation involved in morphogenesis and biological process this GO :0048706 and embryonic skeletal system development and biological process this GO :0048712 and negative regulation of astrocyte differentiation and biological process this GO :0048762 and mesenchymal cell differentiation and biological process this GO :0050679 and positive regulation of epithelial cell proliferation and biological process this GO :0051216 and cartilage development and biological process this GO :0060044 and negative regulation of cardiac muscle cell proliferation and biological process this GO :0060173 and limb development and biological process this GO :0060272 and embryonic skeletal joint morphogenesis and biological process this GO :0060302 and negative regulation of cytokine activity and biological process this GO :0060325 and face morphogenesis and biological process this GO :0060394 and negative regulation of pathway-restricted SMAD protein phosphorylation and biological process this GO :0060425 and lung morphogenesis and biological process this GO :0060513 and prostatic bud formation and biological process this GO :0060676 and ureteric bud formation and biological process this GO :0060825 and fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation and biological process this GO :0061037 and negative regulation of cartilage development and biological process this GO :0061053 and somite development and biological process this GO :0071773 and cellular response to BMP stimulus and biological process this GO :0090090 and negative regulation of canonical Wnt signaling pathway and biological process this GO :0090190 and positive regulation of branching involved in ureteric bud morphogenesis and biological process this GO :0090193 and positive regulation of glomerulus development and biological process this GO :2000313 and regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation and biological process this GO :2001234 and negative regulation of apoptotic signaling pathway and biological process, this GO :0005515 : protein binding, this GO :0005515 : protein binding and also this GO :0019955 : cytokine binding and also this GO :0042803 : protein homodimerization activity, this GO :0019955 : cytokine binding, this GO :0042803 : protein homodimerization activity, noggin |
| Identity: |
7866 |
| Gene: |
NOG |
More about : NOG |
| Long gene name: |
noggin |
| Synonyms gene: |
SYNS1 SYM1 |
| Synonyms gene name: |
synostoses (multiple) syndrome 1 symphalangism 1 (proximal) |
| Locus: |
17q22 |
| Discovery year: |
1999-03-24 |
| GenBank acession: |
U31202 |
| Entrez gene record: |
9241 |
| Pubmed identfication: |
7666191 10080184 11545688 |
| RefSeq identity: |
NM_005450 |
| Havana BLAST/BLAT: |
OTTHUMG00000151770 |